Platelet membrane glycoproteins: A look back into the past and a view to the future

Thrombosis and Haemostasis

Volumn 98, Issue 1, 2007, Pages 49-54

  Nurden, Alan T ^a  

^a Ctr Geriatrie Ctr Hosp Univ B   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; ALPHA2 INTEGRIN; CALCIUM; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; FIBRIN; FIBRINOGEN; FIBRINOGEN RECEPTOR; FIBRONECTIN; GLYCOPEPTIDE; GLYCOPROTEIN IIIA; HEPARAN SULFATE; HYALURONIC ACID; SIALIDASE; THROMBOSPONDIN 1;

ARTICLE; BERNARD SOULIER DISEASE; BLOOD CLOT RETRACTION; CELL SURFACE; CONTROLLED STUDY; CROSSED IMMUNOELECTROPHORESIS; FIBRIN FORMATION; GLANZMANN DISEASE; GLYCOCALYX; HUMAN; IMMUNOGOLD LABELING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SURFACE CHARGE; SURFACE PROPERTY; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; TWO DIMENSIONAL ELECTROPHORESIS;

BERNARD-SOULIER SYNDROME; BIOMEDICAL RESEARCH; FORECASTING; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; THROMBASTHENIA;

EID: 34447521893     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-04-0262     Document Type: Article

References (49)

1. Sheppard BL, French JE. Platelet adhesion in rabbit arteries observed by scanning and transmission electron microscopy. Nature 1970; 225: 1054-1055.
2. Behnke 0. Electron microscopical observations on the surface coating of human blood platelets. J Ultrastruct Res 1968; 24: 51-69.
3. Nurden A, Phillips DR, George JN. Platelet membrane glycoproteins: Historical perspectives. J Thromb Haemost 2006; 4: 3-9.
4. Marcus AJ, Ullman HL, Safier LB. Studies on human platelet gangliosides. J Clin Invest 1972; 51: 2602-2612.
5. Pepper DS, Jamieson GA. Studies on glycoproteins. 3. Isolation of sialyglycopeptides from human platelet membranes. Biochemistry 1969; 8: 3362-3369.
6. Pepper DS, Jamiseon GA. Isolation of a macroglycopeptide from human platelets. Biochemistry 1970; 9: 3706-3713.
7. Barber AJ, Jamieson GA. Isolation of glycopeptides from low- and high-density platelet membranes. Biochemistry 1971; 10: 4711-4717.
8. Nurden AT. Platelet macroglycopeptide. Nature 1974; 251:151-153.
9. Nachman RL, Ferris B. Studies on the proteins of human platelet membranes. J Biol Chem 1972; 247: 4468-4475.
10. Phillips DR. Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane. Biochemistry 1972; 11: 4582-4588.
11. Nachman RL, Hubbard A, Ferris B. Iodination of the human platelet membrane. Studies of the major surface glycoprotein. J Biol Chem 1973; 248: 2928-2936.
12. Caen JP, Castaldi PA, Leclerc JC, et al. Congenital bleeding disorders with long bleeding time and normal platelet count. I. Glanzmann's thrombasthenia. Am J Med 1966; 41: 4-26.
13. Born GVR, Cross MJ. Effects of inorganic ions and of plasma proteins on the aggregation of blood platelets by adenosine diphosphate. J Physiol 1964; 170: 397-414.
14. Nurden AT, Caen JP. An abnormal platelet glycoprotein pattern in three cases of Glanzinann's thrombasthenia. Br J Haematol 1974; 28: 253-260.
15. Nurden AT, Caen JP. Specific roles for platelet surface glycoproteins in platelet function. Nature 1975; 255: 720.
16. Bernard J, Caen J, Jeanneau C, et al. La dystrophie thrombocytaire hémorragipare. Act Hématol 1974; 8: 3-14.
17. Grottum KA, Solum NO. Congenital thrombocytopenia with giant platelets: a defect in the platelet membrane. Br J Haernatol 1969; 16: 277-290.
18. Bithell TC, Parekh SJ, Strong RR. Platelet-function studies in the Bernard-Soulier syndrome. Ann NY Acad Sci 1972; 201: 145-159.
19. Weiss HJ, Tschopp TB, Baumgartner HR, et al. Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium-further implications on the role of the von Willebrand factor in hemostasis. Am J Med 1974; 57: 920-928.
20. Phillips DR, Jenkins CS, Luscher EF, et al. Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature 1975; 257: 599-600.
21. Caen JP, Nurden AT, Jeanneau C, et al. Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to sub-endothelium and with the factor VIII von Willebrand protein. J Lab Clin Med 1976; 87: 586-593.
22. Hagen I, Bjerrum OJ, Solum NO. Characterization of human platelet proteins solubilized with Triton X-100 and examined by crossed immunoelectrophoresis. Reference patterns of extracts from whole platelets and isolated membranes. Eur J Biochem 1979; 99: 9-22.
23. Hagen I, Nurden AT, Bjerrum OJ, et al. Immunochemical evidence for protein abnormalities from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome. J Clin Invest 1980; 65: 722-729.
24. Kunicki TJ, Nurden AT, Pidard D, et al. Characterization of human platelet glycoprotein antigens giving rise to individual immunoprecipitates in crossed immunoelectrophoresis. Blood 1981; 58: 1190-1199.
25. Rosa JP, Kieffer N, Didry D, et al. The human platelet membrane glycoprotein complex GPIIb-IIIa expresses antigenic sites not exposed on the dissociated glycoproteins. Blood 1984; 64: 1246-1253.
26. Phillips DR, Poh Agin PP. Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J Clin Invest 1977; 60: 535-545.
27. Nurden AT, Dupuis D, Kunicki TJ, Caen JP. Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest 1981; 67: 1431-1440.
28. Clemetson KJ, McGregor JL, James E, et al. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 1982; 70: 304-311.
29. Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979; 254: 5357-5363.
30. Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393-1401.
31. Coller BS, Peerschke El, Scudder LE, et al. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 1983; 72: 325-338.
32. Gartner TK, Williams DC, Minion FC, et al. Thrombin-induced platelet aggregation is mediated by a platelet plasma-membrane-bound lectin. Science 1978; 200: 1281-1283.
33. Phillips DR, Jennings LK, Edwards HH. Identification of membrane proteins mediating the interaction of human platelets. J Cell Biol 1980; 86: 77-86.
34. Ginsberg MH, Painter RG, Forsyth J, et al. Thrombin increases expression of fibronectin on the platelet surface. Proc Natl Acad Sci USA 1980; 77: 1049-1053.
35. George JN, Nurden AT, Phillips DR. Molecular defects in interactions of platelets with the vessel wall. N Engl J Med 1984; 311: 1084-1098.
36. Hourdillé P, Hasitz M, Belloc F, et al. Immunocytochemical study of the binding of fibrinogen and thrombospondin to ADP- and thrombin-stimulated human platelets. Blood 1985; 65: 912-920.
37. Legrand C, Dubernard V, Nurden AT. Studies on the mechanism of expression of secreted fibrinogen on the surface of activated platelets. Blood 1989; 73: 1226-1234.
38. Shattil SJ, Hoxie JA, Cunningham M, et al. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107-11114.
39. Heilmann E, Hourdille P, Provost A, et al. Thrombin-induced platelet aggregates have a dynamic structure. Time-dependent redistribution of glycoprotein IIb-IIIa complexes and secreted adhesive proteins. Arterioscler Thromb 1991; 11: 704-718.
40. Coller BS. Anti-GPIIb/IIIa drugs: Curent strategies and future directions. Thromb Haemost 2001; 86: 427-443.
41. Ruggeri ZM, Orie JN, Habermann R, et al. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 2006; 108: 1903-1910.
42. Matuskova J, Chauhan AV, Cambien B, et al. Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler Thromb Vasc Biol 2006; 26: 1391-1396.
43. Xiao T, Takagi J, Coller BS, et al. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004; 432: 59-67.
44. Wegener KL, Partridge AW, Han J, et al. Structural basis of integrin activation by talin. Cell 2007; 128: 171-182.
45. Goschnick MW, Lau LM, Wee JL, et al. Impaired 'outside-in' integrin αIIbβ3 signaling and thrombus stability in TSSC6-deficient mice. Blood 2006; 108: 1911-1918.
46. Arias-Salgado EG, Haj F, Dubois C, et al. PTP-1B is an essential positive regulator of platelet integrin signaling. J Cell Biol 2005; 170: 837-845.
47. Prevost N, Woulfe DS, Jiang H, et al. Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. Proc Natl Acad Sci USA 2005; 102: 9820-9825.
48. Nanda N, André P, Bao M, et al. Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling. Blood 2005; 106: 3028-3034.
49. Zhu L, Bergmeier W, Wu J, et al. Regulated surface expression and shedding support a dual role for Semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci USA 2007; 104: 1621-1626.